# FDA Inspection 1025881 - Medline Industries, Inc. - September 13, 2017

Source: https://www.keypedia.com/records/fda_inspections/medline-industries-inc/ef0a4d98-158d-4c1f-ab24-ab86d8ba75fc
Source feed: FDA_Inspections

> FDA Inspection 1025881 for Medline Industries, Inc. on September 13, 2017. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1025881
- Company Name: Medline Industries, Inc.
- Inspection Date: 2017-09-13
- Classification: No Action Indicated (NAI)
- Project Area: Human Cellular, Tissue, and Gene Therapies
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1112667 - 2019-12-05](https://www.keypedia.com/records/fda_inspections/medline-industries-inc/17d4d971-f94e-481f-a431-55ab586f0b5e)
- [FDA Inspection 925154 - 2015-05-07](https://www.keypedia.com/records/fda_inspections/medline-industries-inc/5991a108-a5f2-4223-a484-27e3a921c8f2)

Company: https://www.keypedia.com/companies/medline-industries-inc/9134cdae-04f1-4425-ba2f-4c1015919f79

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d